Inventor · disambiguated record

Christopher Breder

Also filed as: BREDER CHRISTOPHER · BREDER CHRISTOPHER D

56 granted patents·41 pending applications·1,878 citations·filing 2002–2025

99Inventor score

Technology areasA61P A61K

Files withPURDUE PHARMA LP70 SUPERNUS PHARMACEUTICALS INC15 BREDER CHRISTOPHER3 WRIGHT CURTIS3 BREDER CHRISTOPHER D2

Top patents by PatentIndex Score

97 records

0199US9387174B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·26 cites·22 claims
0299US9387173B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·27 cites·22 claims
0399US9060976B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2012·Granted Jun 23, 2015·72 cites·1 claims
0499US9044435B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Jun 2, 2015·55 cites·20 claims
0599US9040084B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted May 26, 2015·38 cites·9 claims
0699US9034376B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted May 19, 2015·48 cites·19 claims
0799US8999961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 7, 2015·41 cites·8 claims
0899US8871265B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Oct 28, 2014·51 cites·13 claims
0999US8609683B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Dec 17, 2013·85 cites·22 claims
1099US8529948B1Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Sep 10, 2013·80 cites·22 claims
1199US8524275B2Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agentOSHLACK BENJAMIN·Filed 2010·Granted Sep 3, 2013·92 cites·27 claims
1299US8389007B2Pharmaceutical composition containing gelling agentWRIGHT CURTIS·Filed 2008·Granted Mar 5, 2013·94 cites·20 claims
1399US8337888B2Pharmaceutical formulation containing gelling agentWRIGHT CURTIS·Filed 2012·Granted Dec 25, 2012·198 cites·24 claims
1499US7842307B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2002·Granted Nov 30, 2010·221 cites·43 claims
1599US7144587B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agentEURO CELTIQUE SA·Filed 2002·Granted Dec 5, 2006·216 cites·22 claims
1699US7141250B2Pharmaceutical formulation containing bittering agentPURDUE PHARMA LP·Filed 2002·Granted Nov 28, 2006·224 cites·38 claims
1798US9308171B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Apr 12, 2016·25 cites·24 claims
1898US9308170B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 12, 2016·24 cites·17 claims
1997US8465774B2Sequestered antagonist formulationsBREDER CHRISTOPHER·Filed 2006·Granted Jun 18, 2013·52 cites·137 claims
2096US10206881B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Feb 19, 2019·7 cites·7 claims
2196US9872836B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 23, 2018·8 cites·24 claims
2296US9693961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jul 4, 2017·7 cites·17 claims
2396US9101668B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2013·Granted Aug 11, 2015·12 cites·22 claims
2495US10076497B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 18, 2018·6 cites·22 claims
2595US10071057B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 11, 2018·6 cites·25 claims
2695US10064824B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 4, 2018·6 cites·26 claims
2795US9517207B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Dec 13, 2016·6 cites·24 claims
2894US8518443B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2012·Granted Aug 27, 2013·22 cites·21 claims
2994US8231901B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2011·Granted Jul 31, 2012·20 cites·20 claims
3094US7914818B2Opioid agonist formulations with releasable and sequestered antagonistPURDUE PHARMA LP·Filed 2002·Granted Mar 29, 2011·46 cites·21 claims
3193US9877924B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 30, 2018·4 cites·19 claims
3293US9757341B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 12, 2017·4 cites·20 claims
3392US10064825B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Sep 4, 2018·3 cites·13 claims
3490US2025009752A1Method of treatment of attention deficit/hyperactivity disorder (adhd)SUPERNUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
3589US10130586B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Nov 20, 2018·2 cites·20 claims
3689US8815287B2Opiod agonist formulations with releasable and sequestered antagonistPURDUE PHARMA LP·Filed 2013·Granted Aug 26, 2014·8 cites·21 claims
3788US11135171B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
3888US10537526B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2018·Granted Jan 21, 2020·1 cites·7 claims
3988US10500160B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2018·Granted Dec 10, 2019·1 cites·13 claims
4086US7943173B2Pharmaceutical combinations of oxycodone and naloxonePURDUE PHARMA LP·Filed 2002·Granted May 17, 2011·27 cites·38 claims
4185US12121523B2Method of treatment of attention deficit/hyperactivity disorder (ADHD)SUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Oct 22, 2024·0 cites·29 claims
4285US9861583B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 9, 2018·1 cites·7 claims
4385US8758825B2Sequestered antagonist formulationsPURDUE PHARMA LP·Filed 2013·Granted Jun 24, 2014·5 cites·22 claims
4484US9968559B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted May 15, 2018·1 cites·20 claims
4584US9867784B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 16, 2018·1 cites·17 claims
4684US9861582B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 9, 2018·1 cites·22 claims
4783US11458143B2Method of treatment of attention deficit/hyperactivity disorder (ADHD)SUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Oct 4, 2022·0 cites·9 claims
4882US9867783B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jan 16, 2018·1 cites·15 claims
4982US2025228860A1Method of treatment of attention deficit/hyperactivity disorder (adhd)SUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
5079US10201547B2Method of treatment of aggressionSUPERNUS PHARMACEUTICALS INC·Filed 2018·Granted Feb 12, 2019·1 cites·6 claims

Showing the top 50 of 97 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Christopher Breder files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →